Literature DB >> 9525676

Evidence for cooperation between murine leukemia virus Env molecules in mixed oligomers.

A Rein1, C Yang, J A Haynes, J Mirro, R W Compans.   

Abstract

A retroviral Env molecule consists of a surface glycoprotein (SU) complexed with a transmembrane protein (TM). In turn, these complexes are grouped into oligomers on the surfaces of the cell and of the virion. In the case of murine leukemia viruses (MuLVs), the SU moieties are polymorphic, with SU proteins of different viral isolates directed towards different cell surface receptors. During maturation of the released virus particle, the 16 C-terminal residues of TM (the R peptide or p2E) are removed from the protein by the viral protease; this cleavage is believed to activate the membrane-fusing potential of MuLV Env. We have tested the possibility that different MuLV Env proteins in the same cell can interact with each other, both physically and functionally, in mixed oligomers. We found that coexpressed Env molecules can be precipitated out of cell lysates by antiserum which reacts with only one of them. Furthermore, they can evidently cooperate with each other: if one Env species lacks the R peptide, then it can apparently induce fusion if the SU protein of the other Env species encounters its cognate receptor on the surface of another cell. This functional interaction between different Env molecules has a number of implications with respect to the mechanism of induction of membrane fusion, for the genetic analysis of Env function, and for the design of targeted retroviral vectors for gene therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525676      PMCID: PMC109843     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Atomic structure of the ectodomain from HIV-1 gp41.

Authors:  W Weissenhorn; A Dessen; S C Harrison; J J Skehel; D C Wiley
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

2.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

3.  Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product.

Authors:  J G Sutcliffe; T M Shinnick; N Green; F T Liu; H L Niman; R A Lerner
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

4.  Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer.

Authors:  T H Chu; R Dornburg
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

5.  Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide.

Authors:  N Green; T M Shinnick; O Witte; A Ponticelli; J G Sutcliffe; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

6.  Functional interactions between monomers of the retroviral envelope protein complex.

Authors:  Y Zhao; S Lee; W F Anderson
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Entry of murine retrovirus into mouse fibroblasts.

Authors:  K B Andersen; B A Nexø
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

8.  Different recombinant murine leukemia viruses use different cell surface receptors.

Authors:  A Rein; A Schultz
Journal:  Virology       Date:  1984-07-15       Impact factor: 3.616

9.  Ligand-directed retroviral targeting of human breast cancer cells.

Authors:  X Han; N Kasahara; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

10.  Retrovirus envelope domain at 1.7 angstrom resolution.

Authors:  D Fass; S C Harrison; P S Kim
Journal:  Nat Struct Biol       Date:  1996-05
View more
  17 in total

1.  Identification of the block in targeted retroviral-mediated gene transfer.

Authors:  Y Zhao; L Zhu; S Lee; L Li; E Chang; N W Soong; D Douer; W F Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein.

Authors:  E Bachrach; M Marin; M Pelegrin; G Karavanas; M Piechaczyk
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments.

Authors:  D Lavillette; A Ruggieri; S J Russell; F L Cosset
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Stoichiometry of murine leukemia virus envelope protein-mediated fusion and its neutralization.

Authors:  Wu Ou; Jonathan Silver
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

5.  Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells.

Authors:  D L Lerner; J H Elder
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.

Authors:  Chisu Song; Keith Micoli; Helena Bauerova; Iva Pichova; Eric Hunter
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41.

Authors:  K Salzwedel; E A Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

8.  Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction.

Authors:  T Zavorotinskaya; L M Albritton
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

9.  Cooperative cleavage of the R peptide in the Env trimer of Moloney murine leukemia virus facilitates its maturation for fusion competence.

Authors:  Robin Löving; Malin Kronqvist; Mathilda Sjöberg; Henrik Garoff
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

10.  Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein.

Authors:  T Zavorotinskaya; L M Albritton
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.